Concepedia

Michael Gonzalez

MG

Statistics

Publications

27

Citations

2K

H-Index

20

Active since

1999

Affiliations

Imperial College Healthcare NHS Trust(Current)

Hutchison/MRC Research Centre

Royal Marsden NHS Foundation Trust

Institute of Cancer Research

Charing Cross Hospital

Michael Gonzalez is an author at Imperial College Healthcare NHS Trust specializing in oncology, medicine, and molecular oncology.

ORCID

Publications per year

1999–2024

27

Publications

27

Association of Prior Antibiotic Treatment With Survival and Response to Immune Checkpoint Inhibitor Therapy in Patients With Cancer

David J. Pinato, Sarah Howlett, Diego Ottaviani et al. · JAMA Oncology · 2019 · 593 citations · Full text

, , +15

Minichromosome Maintenance Protein 2 Is a Strong Independent Prognostic Marker in Breast Cancer

Michael Gonzalez, Sarah E. Pinder, Grace Callagy et al. · Journal of Clinical Oncology · 2003 · 160 citations

, , +13

Vitamin A mediates conversion of monocyte-derived macrophages into tissue-resident macrophages during alternative activation

Uma Mahesh Gundra, Natasha Girgis, Michael Gonzalez et al. · Nature Immunology · 2017 · 157 citations

, , +15

Geminin is essential to prevent endoreduplication and to form pluripotent cells during mammalian development

Michael Gonzalez, Kikuë Tachibana, David J. Adams et al. · Genes & Development · 2006 · 126 citations · Full text

, , +14

An immunohistochemical examination of the expression of E-cadherin, ?- and ?/?-catenins, and ?2- and ?1-integrins in invasive breast cancer

Michael Gonzalez, Sarah E. Pinder, P.M. Wencyk et al. · The Journal of Pathology · 1999 · 99 citations

, , +17

1–5 of 27